Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALGEN.PA
- Price
- 2.96
- Stock movement up
- +0.05 (1.72%)
- Company name
- Genoway
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Biotechnology
- Market cap
- 24.04M
- Ent value
- -
- Price/Sales
- 0.78
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 10.57
- Forward P/E
- -
- PEG
- -
- EPS growth
- 12.64%
- 1 year return
- -25.06%
- 3 year return
- -5.16%
- 5 year return
- 4.63%
- 10 year return
- 2.87%
Last updated: 2025-04-12
DIVIDENDS
ALGEN.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 10.57 |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 17.81 |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.78 |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 8.12M |
| EPS (TTM) | 0.25 |
| FCF per share (TTM) | -0.18 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 30.76M |
| Gross profit (TTM) | 21.08M |
| Operating income (TTM) | -7.33M |
| Net income (TTM) | 2.27M |
| EPS (TTM) | 0.25 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 68.54% |
| Operating margin (TTM) | -23.84% |
| Profit margin (TTM) | 7.39% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 0.00 |
| Total current assets | 0.00 |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 0.00 |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 0.00 |
| Total liabilities | 0.00 |
| Shareholder's equity | 0.00 |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -891.64K |
| Capital expenditures (TTM) | 752.25K |
| Free cash flow (TTM) | -1.64M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.88 |
| Daily high | 2.96 |
| Daily low | 2.80 |
| Daily Volume | 12K |
| All-time high | 7.39 |
| 1y analyst estimate | 6.60 |
| Beta | 0.55 |
| EPS (TTM) | 0.25 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALGEN.PA | S&P500 | |
| Current price drop from All-time high | -59.95% | -12.89% |
| Highest price drop | -87.55% | -56.47% |
| Date of highest drop | 2 Feb 2009 | 9 Mar 2009 |
| Avg drop from high | -62.55% | -11.07% |
| Avg time to new high | 765 days | 12 days |
| Max time to new high | 4575 days | 1805 days |
COMPANY DETAILS
Marketcap
24.04M
Marketcap category
Small-cap
Description
genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found